China Mammography Market Size (2024 - 2029)

The China Mammography Market is projected to experience significant growth over the forecast period, driven by an increase in breast cancer cases and advancements in breast imaging technology. The market's expansion is further supported by investments in screening campaigns and improved access to mammography services, even in remote areas. Despite challenges such as the risk of radiation exposure and inadequate reimbursement for screenings, the market is expected to grow as awareness and demand for mammography increase.

Market Size of China Mammography Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
China Mammography Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 121.25 Million
Market Size (2029) USD 206.91 Million
CAGR (2024 - 2029) 11.24 %
Market Concentration Medium

Major Players

China Mammography Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

China Mammography Market Analysis

The China Mammography Market size is estimated at USD 121.25 million in 2024, and is expected to reach USD 206.91 million by 2029, growing at a CAGR of 11.24% during the forecast period (2024-2029).

  • COVID-19 significantly impacted the market studied due to the closure of clinics and diagnostic facilities, causing delays in early diagnosis that had an immediate effect on cancer patients. According to the study published in the Chinese Journal of General Surgery in February 2020, patients with breast tumors had particularly low immunity and were susceptible to the new coronavirus. The low immunity among breast cancer patients for COVID-19 led to a decrease in attendees for breast cancer screening in China. However, during the late pandemic, the market saw a surge in screening for lagging cases, and post-pandemic, the market attained pace, thereby showing significant growth over the forecast period.
  • Factors such as the growing incidences of breast cancer, technological advancements in the field of breast imaging, and the investment from various organizations in breast cancer screening campaigns are boosting the growth of the market studied. Additionally, according to news published in Science and Technology Daily in March 2021, breast cancer patients in China will reach 2.5 million in 2021, of which men account for about 1%. Furthermore, data from Globocan 2020 published by the International Agency for Research on Cancer shows that there were 416,000 new instances of breast cancer in China in 2020, with a projected increase to 481,000 cases by 2040. The number of patients looking for mammograms at hospitals across China is anticipated to increase as breast cancer incidence rises, thereby accelerating market growth.
  • The increase in awareness of breast cancer and access to mammography screening services is another factor contributing to the market growth. For instance, according to an announcement made in July 2021 by Shenzhen Anke High-tech Co. Ltd, a manufacturer of mammography equipment, the isolated Chinese Qinghai-Tibet plateau will have access to mammography services. Thus, it was anticipated that more people would go for breast scans at hospitals equipped with mammography equipment, thereby fuelling market growth.
  • Thus, factors such as the rising incidence of breast cancer and rising initiatives from the key market players are anticipated to drive market growth. However, the risk of adverse effects from radiation exposure and lack of proper reimbursement for breast cancer screening are expected to hinder the market growth.

China Mammography Industry Segmentation

Mammography refers to a standard diagnostic and screening technique that is used to screen breast tissues to check the presence of a malignant tumor. In mammography, low-frequency X-rays are passed through the breast to locate tumors. 

The China mammography market is segmented by product type (digital systems, analog systems, breast tomosynthesis, and other product types) and end-user (hospitals, specialty clinics, and diagnostic centers).

The report offers the value (in USD) for the above segments.

By Product Type
Digital Systems
Analog Systems
Breast Tomosynthesis
Other Product Types
By End-User
Hospitals
Specialty Clinics
Diagnostic Centers
Need A Different Region Or Segment?
Customize Now

China Mammography Market Size Summary

The China mammography market is poised for significant growth over the forecast period, driven by an increase in breast cancer incidences and advancements in breast imaging technologies. The market experienced initial setbacks due to the COVID-19 pandemic, which led to delays in screenings and a temporary decline in attendance. However, the post-pandemic period saw a resurgence in screenings, contributing to the market's recovery and expansion. The growing awareness of breast cancer, coupled with strategic investments in screening campaigns and technological innovations like digital breast tomosynthesis, is expected to further propel market growth. These advancements offer improved detection and characterization of tumors, addressing limitations in traditional imaging methods.

The market landscape is characterized by moderate competition among key players such as GE Healthcare, Fujifilm Holdings Corporation, Siemens Healthineers AG, Carestream Health Inc., and Koninklijke Philips NV. These companies are actively engaging in product launches and brand awareness initiatives to strengthen their market presence. The introduction of AI-driven screening software and advanced imaging technologies is anticipated to enhance diagnostic capabilities and increase the demand for mammography services. Despite challenges such as radiation exposure risks and reimbursement issues, the market is expected to benefit from rising healthcare expenditures and increased access to screening services, particularly in underserved regions like the Qinghai-Tibet plateau.

Explore More

China Mammography Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Burden of Breast Cancer

      2. 1.2.2 Technological Advancements in the Field of Breast Imaging

      3. 1.2.3 Investment from Various Organizations in Breast Cancer Screening Campaigns

    3. 1.3 Market Restraints

      1. 1.3.1 Risk of Adverse Effects from Radiation Exposure

      2. 1.3.2 Lack of Proper Reimbursement for Breast Cancer Screening

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Product Type

      1. 2.1.1 Digital Systems

      2. 2.1.2 Analog Systems

      3. 2.1.3 Breast Tomosynthesis

      4. 2.1.4 Other Product Types

    2. 2.2 By End-User

      1. 2.2.1 Hospitals

      2. 2.2.2 Specialty Clinics

      3. 2.2.3 Diagnostic Centers

China Mammography Market Size FAQs

The China Mammography Market size is expected to reach USD 121.25 million in 2024 and grow at a CAGR of 11.24% to reach USD 206.91 million by 2029.

In 2024, the China Mammography Market size is expected to reach USD 121.25 million.

China Mammography Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)